Top 29 Asthma treatment startups
Nov 14, 2025
Like
24
These startups develop new diagnostics and treatment technologies for Asthma, like gene therapy, AI imaging analyses, new spirometers, sensors, drugs and drug-delivery solutions...
1
Country: USA | Funding: $250M
Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.
Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.
2
Country: USA | Funding: $207M
Triveni Bio focuses on the identification of novel disease by combining human genetics and precision medicine.
Triveni Bio focuses on the identification of novel disease by combining human genetics and precision medicine.
3
Country: China | Funding: $195M
Connect Biopharmaceuticals is a developer of novel immune modulators for the treatment of serious autoimmune diseases and inflammation.
Connect Biopharmaceuticals is a developer of novel immune modulators for the treatment of serious autoimmune diseases and inflammation.
4
Country: USA | Funding: $185.9M
AnaptysBio is a therapeutic antibody product company and the leader in the use of somatic hypermutation, or SHM, for antibody discovery and optimization. SHM is the body's natural process for generating potent antibodies to fight disease.
AnaptysBio is a therapeutic antibody product company and the leader in the use of somatic hypermutation, or SHM, for antibody discovery and optimization. SHM is the body's natural process for generating potent antibodies to fight disease.
5
Country: UK | Funding: £18M
A drug discovery and development company focused on advancing novel approaches for severe respiratory conditions
A drug discovery and development company focused on advancing novel approaches for severe respiratory conditions
6
Country: UK | Funding: £68.8M
Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.
Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.
7
Country: USA | Funding: $33.2M
VIDA is a leader in quantitative lung analysis for COPD, emphysema and asthma, establishing objective, reproducible and quantitative
VIDA is a leader in quantitative lung analysis for COPD, emphysema and asthma, establishing objective, reproducible and quantitative
8
Country: Sweden | Funding: $28.2M
NuvoAir combines hardware, software and data to improve lives of people suffering from respiratory conditions
NuvoAir combines hardware, software and data to improve lives of people suffering from respiratory conditions
9
Country: USA | Funding: $23.3M
Pneuma Respiratory is focused on creating therapeutic treatments for diseases of the lungs using a digital first platform for inhaled drug delivery. Our focus is to improve the potential effectiveness of currently available and novel drugs, with the initial targets being approved therapeutics for asthma and COPD.
Pneuma Respiratory is focused on creating therapeutic treatments for diseases of the lungs using a digital first platform for inhaled drug delivery. Our focus is to improve the potential effectiveness of currently available and novel drugs, with the initial targets being approved therapeutics for asthma and COPD.
10
Country: USA | Funding: $16.8M
Cohero developed a connected spirometer to assess lung function and medication adherence in asthma and COPD patients. It was designed to be a clinical grade medical device to function as a barometer for lung function. It also produced a patient-facing app that helps users track their data.
Cohero developed a connected spirometer to assess lung function and medication adherence in asthma and COPD patients. It was designed to be a clinical grade medical device to function as a barometer for lung function. It also produced a patient-facing app that helps users track their data.
11
Country: New Zealand | Funding: $15.4M
Adherium provides digital health solutions for respiratory conditions including asthma and COPD.
Adherium provides digital health solutions for respiratory conditions including asthma and COPD.
12
Country: Cyprus | Funding: €10M
Liita Care is a MedTech company focused on Respiratory Health. We are committed to improve quality of life for patients and healthy consumers by developing and manufacturing new and better therapies and medical devices for respiratory health management.
Liita Care is a MedTech company focused on Respiratory Health. We are committed to improve quality of life for patients and healthy consumers by developing and manufacturing new and better therapies and medical devices for respiratory health management.
13
Country: UK | Funding: $4M
Sensio Air is a healthcare analytics company that helps people with asthma and allergy predict prevent and manage their symptoms.
Sensio Air is a healthcare analytics company that helps people with asthma and allergy predict prevent and manage their symptoms.
14
Country: Netherlands | Funding: $7.4M
Lapsi Health is a Medical Technology company developing Digital Biomarkers from medical sound analytics. In particular it develops digital stethoscope for detecting childhood asthma.
Lapsi Health is a Medical Technology company developing Digital Biomarkers from medical sound analytics. In particular it develops digital stethoscope for detecting childhood asthma.
15
Country: Germany | Funding: €4.7M
VisionHealth supports patients with chronic lung diseases who are dependent on their inhaler.
VisionHealth supports patients with chronic lung diseases who are dependent on their inhaler.
16
Country: UK | Funding: £2.5m
Pure is a private medical facility, the first of its kind in the UK, providing innovative science-backed treatments & therapies.
Pure is a private medical facility, the first of its kind in the UK, providing innovative science-backed treatments & therapies.
17
Country: UK | Funding: $3M
Arete Medical Technologies is a startup creating medical devices and software for precision approaches to chronic diseases, starting with asthma and COPD.
Arete Medical Technologies is a startup creating medical devices and software for precision approaches to chronic diseases, starting with asthma and COPD.
18
Country: Belgium | Funding: €1M
ArtiQ developed AI-based software that automatically processes pulmonary function test (PFT) data and generates a clinical report. It provides cloud-based coupling and synchronization with either electronic patient records or directly with PFT machines. The AI report is stored in the patient file immediately.
ArtiQ developed AI-based software that automatically processes pulmonary function test (PFT) data and generates a clinical report. It provides cloud-based coupling and synchronization with either electronic patient records or directly with PFT machines. The AI report is stored in the patient file immediately.
19
Country: Israel
NE Field Diagnostics develops an innovative technology for pulmonary function testing and monitoring
NE Field Diagnostics develops an innovative technology for pulmonary function testing and monitoring
20
Country: Denmark
Sonohaler is a digital health company that empowers people with asthma live an active and healthy life.
Sonohaler is a digital health company that empowers people with asthma live an active and healthy life.
